NM_004239.4:c.*1294A>G

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_004239.4(TRIP11):​c.*1294A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00145 in 205,842 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0014 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0017 ( 1 hom. )

Consequence

TRIP11
NM_004239.4 3_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.326

Publications

0 publications found
Variant links:
Genes affected
TRIP11 (HGNC:12305): (thyroid hormone receptor interactor 11) This gene was identified based on the interaction of its protein product with thyroid hormone receptor beta. This protein is associated with the Golgi apparatus. The N-terminal region of the protein binds Golgi membranes and the C-terminal region binds the minus ends of microtubules; thus, the protein is thought to play a role in assembly and maintenance of the Golgi ribbon structure around the centrosome. Mutations in this gene cause achondrogenesis type IA.[provided by RefSeq, Mar 2010]
TRIP11 Gene-Disease associations (from GenCC):
  • achondrogenesis type IA
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • TRIP11-related skeletal dysplasia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00137 (208/152322) while in subpopulation AMR AF = 0.00346 (53/15300). AF 95% confidence interval is 0.00272. There are 1 homozygotes in GnomAd4. There are 95 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004239.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRIP11
NM_004239.4
MANE Select
c.*1294A>G
3_prime_UTR
Exon 21 of 21NP_004230.2Q15643-1
TRIP11
NM_001321851.1
c.*1294A>G
3_prime_UTR
Exon 21 of 21NP_001308780.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRIP11
ENST00000267622.8
TSL:1 MANE Select
c.*1294A>G
3_prime_UTR
Exon 21 of 21ENSP00000267622.4Q15643-1
TRIP11
ENST00000913145.1
c.*1294A>G
3_prime_UTR
Exon 21 of 21ENSP00000583204.1
TRIP11
ENST00000876362.1
c.*1294A>G
3_prime_UTR
Exon 20 of 20ENSP00000546421.1

Frequencies

GnomAD3 genomes
AF:
0.00137
AC:
209
AN:
152204
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00347
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00193
Gnomad OTH
AF:
0.00287
GnomAD4 exome
AF:
0.00168
AC:
90
AN:
53520
Hom.:
1
Cov.:
0
AF XY:
0.00161
AC XY:
40
AN XY:
24822
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
2344
American (AMR)
AF:
0.00203
AC:
3
AN:
1476
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3380
East Asian (EAS)
AF:
0.00
AC:
0
AN:
8246
South Asian (SAS)
AF:
0.00
AC:
0
AN:
474
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40
Middle Eastern (MID)
AF:
0.00309
AC:
1
AN:
324
European-Non Finnish (NFE)
AF:
0.00219
AC:
72
AN:
32806
Other (OTH)
AF:
0.00316
AC:
14
AN:
4430
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00137
AC:
208
AN:
152322
Hom.:
1
Cov.:
32
AF XY:
0.00128
AC XY:
95
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.000361
AC:
15
AN:
41572
American (AMR)
AF:
0.00346
AC:
53
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.000283
AC:
3
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00193
AC:
131
AN:
68034
Other (OTH)
AF:
0.00284
AC:
6
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
12
24
37
49
61
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000318
Hom.:
0
Bravo
AF:
0.00159

ClinVar

ClinVar submissions as Germline
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Achondrogenesis, type IA (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
5.4
DANN
Benign
0.62
PhyloP100
0.33
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143185383; hg19: chr14-92434723; API